Induction therapy in recurrent head and neck squamous cell carcinoma: is it time to consider response as a determinant of treatment selection? | Transl Cancer Res;12(4): 697-700, 2023 Apr 28. | MEDLINE

Contenido principal 1 Búsqueda 2 Pie de página 3

+A A -A Alto contraste

Induction therapy in recurrent head and neck squamous cell carcinoma: is it time to consider response as a determinant of treatment selection?

Tasoulas, Jason; Sheth, Siddharth.

Afiliación

Tasoulas J; Department of Otolaryngology-Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Sheth S; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Transl Cancer Res ; 12(4): 697-700, 2023 Apr 28.

Article en En | MEDLINE | ID: mdl-37180661

Palabras clave

Head and neck squamous cell carcinoma (HNSCC); induction; radiotherapy; recurrent; systemic therapy

Añadir a Mi BVS

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Añadir a Mi BVS

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos